Novartis
Novartis is a Swiss multinational pharmaceutical company known for its innovative medicines and commitment to research and development. It has a strong presence in the global healthcare market and has been recognized for its contributions to various therapeutic areas, including oncology and cardiovascular health.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Argentina | 1 | 6.00 | 0.08% | +0% | 45,195,774 | 34,084 | $450,000 | 339$ |
| Totals | 1 | 45,195,774 | 34,084 | $450,000 | 339$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Argentina:
The government and the laboratory Novartis were refining the conditions of a long renegotiation.
6
Slovenia:
Novartis is mentioned as a foreign investor contributing to the development of the pharmaceutical sector in Slovenia.
7
Switzerland:
Novartis is mentioned as a pharmaceutical company that has begun considering production relocation to the USA.
5
Switzerland:
Novartis has expressed intentions to expand its production in the USA.
5
Germany:
Novartis is another major pharmaceutical company based in Switzerland.
5
Germany:
Novartis is also under pressure from Trump to reduce their prices in the USA.
5
Switzerland:
In Switzerland, ABB and Novartis are reporting this Thursday.
5
Switzerland:
Novartis has not yet made any site selections for its investment program in the USA.
5
Switzerland:
Novartis is not expected to launch products with a significant impact on the market.
4
Canada:
Swiss pharma company Novartis pledged $23 billion in investments.
7